Rationale, completeness and quality of evidence for the use of ursodeoxycholic acid in neonatal hyperbilirubinemia
Background. Systematic reviews are considered the highest evidence of the effectiveness and safety of treatment methods used in clinical practice. The veracity of a results and conclusions of systematic reviews is directly related to their quality. The aim of the study is an assessment of the curren...
Saved in:
| Main Author: | Olesya V. Zakharova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2024-05-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/2436 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Infants Treated with Photo-therapy: A Single-Blind Randomized Clinical Trial
by: Mohammad Sobhani Shahmirzadi, et al.
Published: (2024-10-01) -
Risk Factor Analysis for Late-onset Neonatal Hyperbilirubinemia in Taiwanese Infants
by: Mi-Shu Huang, et al.
Published: (2009-12-01) -
Yinzhihuang injection as adjuvant treatment for neonatal hyperbilirubinemia: a systematic review and meta-analysis of randomized clinical trials
by: Junqiang Li, et al.
Published: (2024-12-01) -
Outcomes of neonatal hyperbilirubinemia and associated factors at a tertiary hospital in Ghana
by: Naana Ayiwa Wireko Brobby, et al.
Published: (2025-04-01) -
A Russian version of AMSTAR 2: validation and guidance
by: D. V. Kvashnina, et al.
Published: (2022-07-01)